Medi Assist Healthcare Announces Board Changes and Strategic Leadership Updates

2 min read     Updated on 06 Feb 2026, 06:39 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Medi Assist Healthcare Services Limited announced significant board changes with the appointment of Ms. Sunita Rebecca Cherian as Additional Director and the completion of Ms. Himani Kapadia's tenure as Independent Director. The company also reported Q3 FY26 consolidated revenue growth of 28.90% to ₹2,396.78 million, though net profit declined due to exceptional items.

31928997

*this image is generated using AI for illustrative purposes only.

Medi Assist Healthcare Services Limited's Board of Directors approved significant leadership changes and strategic appointments at their meeting held on February 06, 2026, alongside the company's unaudited consolidated and standalone financial results for Q3 FY26.

Key Board Appointments and Leadership Changes

The Board appointed Ms. Sunita Rebecca Cherian (DIN: 10188170) as an Additional Director (Non-Executive, Non-Independent Director) effective February 06, 2026. With over 30 years of experience across various functions, she will also serve as a Member of the Nomination & Remuneration Committee and Corporate Social Responsibility Committee.

Leadership Change: Details
New Appointment: Ms. Sunita Rebecca Cherian
Position: Additional Director (Non-Executive, Non-Independent)
Committee Roles: Nomination & Remuneration, CSR
Effective Date: February 06, 2026
Experience: Over 30 years across various functions

Ms. Sunita's career spans Sales, Human Capital Strategy, Board Strategy, Total Rewards Strategy, Workforce Transitions, Mergers & Acquisitions, Organizational Design, HR Shared Services, Sustainability, and Inclusion & Diversity. She previously served as Chief Culture Officer & Senior Vice President – Corporate Human Resources at Wipro Limited.

Director Tenure Completion

Ms. Himani Atul Kapadia (DIN: 00761555) will complete her second and final term as an Independent Director on March 14, 2026. She will cease to be an Independent Director and Member of the Audit Committee, Corporate Social Responsibility Committee and Nomination and Remuneration Committee from the close of business hours on March 14, 2026.

Transition Details: Information
Director: Ms. Himani Atul Kapadia
Tenure Completion: March 14, 2026
Current Role: Independent Director
Committee Memberships: Audit, CSR, Nomination & Remuneration

Subsidiary Board Changes

The Board nominated Mr. Madhavan Ganesan (DIN: 01674529), Independent Director on the Board of Medi Assist Insurance TPA Private Limited, material wholly owned subsidiary with effect from March 15, 2026. This appointment is subject to approval of the Board of MAITPA and other requisite approvals.

Financial Performance Overview

The company demonstrated strong revenue growth during Q3 FY26, with consolidated revenue from operations reaching ₹2,396.78 million compared to ₹1,859.74 million in Q3 FY25. For the nine-month period, consolidated revenue grew to ₹6,627.81 million from ₹5,344.49 million in the corresponding period of the previous year.

Metric: Q3 FY26 Q3 FY25 Change (%)
Consolidated Revenue: ₹2,396.78 million ₹1,859.74 million +28.90%
Consolidated Total Income: ₹2,472.42 million ₹1,904.01 million +29.90%
Profit Before Exceptional Items: ₹226.63 million ₹272.05 million -16.70%
Net Profit (Consolidated): ₹41.36 million ₹299.74 million -86.20%

Meeting Details and Compliance

The Board meeting commenced at 02:00 p.m. (IST) and concluded at 05:15 p.m. (IST) on February 06, 2026. All disclosures were made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the information has been made available on the company's website at www.mediassist.in .

Historical Stock Returns for Medi Assist Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%+1.19%-11.94%-25.54%-29.31%-13.03%
like19
dislike

Medi Assist Healthcare Services Schedules Board Meeting for February 6, 2026 to Consider Q3FY26 Financial Results

1 min read     Updated on 30 Jan 2026, 04:43 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Medi Assist Healthcare Services Limited has scheduled its Board of Directors meeting for February 6, 2026, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The company has notified stock exchanges under SEBI listing regulations, with trading window restrictions in effect from January 1, 2026, until 48 hours after results declaration. An earnings conference call is planned for February 9, 2026, at 08:30 am IST, featuring senior management including Chairman Dr. Vikram Chhatwal, CEO Mr. Satish Gidugu, and CFO Mr. Sandeep Daga.

31317237

*this image is generated using AI for illustrative purposes only.

Medi assist healthcare Services Limited has officially notified stock exchanges about its upcoming board meeting scheduled for February 6, 2026, to deliberate on the company's third quarter financial performance for fiscal year 2026.

Board Meeting Details

The Board of Directors meeting has been convened under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary agenda involves consideration and approval of unaudited standalone and consolidated financial results for specific reporting periods.

Parameter: Details
Meeting Date: Friday, February 6, 2026
Results Period: Quarter and nine months ended December 31, 2025
Result Type: Unaudited standalone and consolidated
Regulatory Framework: SEBI Listing Regulations

Trading Window Restrictions

In compliance with insider trading regulations, the company has implemented trading restrictions for designated persons. The trading window closure affects company insiders and their immediate relatives during the sensitive period surrounding financial results.

Restriction Details: Information
Window Closure Start: January 1, 2026
Closure Duration: Until 48 hours after results declaration
Applicable Regulations: SEBI (Prohibition of Insider Trading) Regulations, 2015
Affected Parties: Designated Persons and immediate relatives

Earnings Conference Call

The company has arranged an earnings conference call to discuss the quarterly financial results with stakeholders. The call will feature key management personnel providing insights into the company's performance.

Call Participants

S.No. Name Designation
1. Dr. Vikram Chhatwal Chairman and Whole-time Director
2. Mr. Satish Gidugu Chief Executive Officer and Whole-time Director
3. Mr. Sandeep Daga Chief Financial Officer

Conference Call Details

Parameter: Information
Date: Monday, February 9, 2026
Time: 08:30 am IST
Registration: Pre-registration required via provided link
Contact: investor.relations@mediassist.in

Communication and Compliance

The formal intimation has been submitted to both the National Stock Exchange of India Limited and BSE Limited, ensuring compliance with listing requirements. The notification was signed by Rashmi B V, Company Secretary & Compliance Officer, with ICSI Membership No: A38729, and will be uploaded to the company's official website for public access.

Historical Stock Returns for Medi Assist Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%+1.19%-11.94%-25.54%-29.31%-13.03%
like15
dislike

More News on Medi Assist Healthcare

1 Year Returns:-29.31%